早期的P2X7受体激活减轻新生儿B组链球菌感染的严重程度和长期的神经发育障碍
Sales Fialho1, Irina Amorim2, Clara Quintas3
1Laboratory of Immunology, Department of ImmunoPhysiology and Pharmacology, ICBAS - School of Medicine and Biomedical Sciences - University of Porto, Porto, Portugal.
International immunopharmacology
|December 31, 2025
概括
在新生小鼠中激活P2X7受体 (P2X7R) 可对抗B组链球菌 (GBS) 感染,降低死亡率并预防长期脑损伤和认知缺陷.
科学领域:
- 神经免疫学 神经免疫学
- 新生儿败血症 新生儿败血症
- 传染性疾病 传染性疾病
背景情况:
- 新生儿B组链球菌 (GBS) 感染导致显著的死亡率和神经发育问题.
- 失调的免疫反应和神经炎症使GBS败血症治疗复杂化.
- 在感染期间,P2X7受体 (P2X7R) 在炎症和神经炎症过程中至关重要.
研究的目的:
- 研究P2X7R调制对新生儿GBS感染中的免疫和神经元功能障碍的影响.
- 在新生儿GBS败血症模型中评估P2X7R激活或阻断的治疗潜力.
主要方法:
- 新生小鼠从出生后的第1天到第4天接受了P2X7R激活剂 (Bz-ATP) 或抗剂 (A740003) 的治疗.
- 评估的生存率,细菌传播,细胞因子 (TNF-α,IL-1β,IL-10),中性粒细胞招募,质激活,大脑病理和神经发育结果.
- 在成年期评估长期的认知和焦虑类行为.
主要成果:
- 激活P2X7R显著改善了生存率,减少了疾病的严重程度,并减少了细菌负担.
- 免疫反应从抗炎性 (IL-10) 转变为促炎性 (TNF-α),增强中性粒细胞的招募.
- 激活P2X7R可以防止GBS引起的脑损伤,保护海马神经元,改善长期的认知功能和焦虑水平.
- P2X7R封锁没有提供保护.
结论:
- 早期P2X7R激活有效地打击新生儿GBS死亡率,并预防长期的神经发育障碍.
- 准P2X7R代表了一种潜在的神经免疫治疗策略,用于改善早期感染后的结果.
相关概念视频
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...


